NCT03426527View on ClinicalTrials.gov

Dexmedetomidine for Bilateral Superficial Cervical Plexus Block for Reconstructive Tracheal Surgery

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

March 1, 2018

Primary Completion Date

September 1, 2018

Study Completion Date

October 1, 2018

Conditions
Tracheal Reconstruction
Interventions
DRUG

Levobupivacaine

Following induction of anaesthesia, patients will receive ultrasound guided bilateral superficial cervical plexus block with levobupivacaine

DRUG

Levobupivacaine-Dexmedetomidine

Following induction of anaesthesia, patients will receive ultrasound guided bilateral superficial cervical plexus block with levobupivacaine in conjunction with dexmedetomidine

OTHER

General Anaesthesia

Using propofol, fentanyl and atracurium

Trial Locations (1)

050

Mansoura University, Central Hospital, Oto-Rhino-Laryngology anesthesia Unit, Al Mansurah

All Listed Sponsors
lead

Mansoura University

OTHER

NCT03426527 - Dexmedetomidine for Bilateral Superficial Cervical Plexus Block for Reconstructive Tracheal Surgery | Biotech Hunter | Biotech Hunter